NATO says reinforcements arriving in Kosovo after clashes last week

BRUSSELS (Reuters) – Reinforcements for NATO’s peacekeeping force have begun to arrive in Kosovo following last week’s unrest in the north of the country, the alliance said on Monday. Violence flared after Kosovo authorities installed ethnic Albanian mayors in offices in northern municipalities after being elected on a turnout of just 3.5% after Serbs who…

Read More

European shares in the red as downbeat U.S. data stokes growth concerns

By Shreyashi Sanyal and Amruta Khandekar (Reuters) -European shares dipped on Monday as investors took profits after last week’s rebound, as news of weak U.S. business activity stirred up economic slowdown worries and eclipsed gains in telecom stocks. The pan-European STOXX 600 index ended 0.4% lower after a survey showed the U.S. services sector barely…

Read More

Biden plans Chicago fundraiser with billionaire Illinois governor Pritzker

By Trevor Hunnicutt and Jarrett Renshaw WASHINGTON (Reuters) – U.S. President Joe Biden’s Democratic allies are planning a private Chicago fundraiser with billionaire Illinois governor J.B. Pritzker as soon as this month, two people briefed on the president’s plans say. A specific date for the tentative event had not been confirmed and a spokesman for…

Read More

Aid group NRC resumes work with female staff in Taliban heartland

By Michelle Nichols UNITED NATIONS (Reuters) – An international aid agency in Afghanistan has resumed operations in the southern province of Kandahar – the birthplace of the Taliban and home to its supreme spiritual leader – after its Afghan female staff were allowed to return to work. The move comes after Norwegian Refugee Council (NRC)…

Read More

Analysis-Stelara patent deal puts J&J back on path to $57 billion 2025 revenue forecast

By Patrick Wingrove (Reuters) – Johnson & Johnson’s legal settlement with Amgen Inc to delay a biosimilar version of its blockbuster psoriasis treatment Stelara until January 2025 could make the drug a larger contributor to J&J’s 2024 and 2025 sales than Wall Street is forecasting. Stelara, introduced in 2009, has been J&J’s top-selling drug since…

Read More

UnitedHealth offers over $3 billion for home health firm Amedisys

By Leroy Leo (Reuters) – UnitedHealth Group on Monday made a surprise $3.26 billion all-cash offer to acquire Amedisys Inc, pitting itself against another healthcare company set to buy the home health and hospice care firm. Interest in the home health sector has jumped since the pandemic as patients and caregivers increasingly prefer accessing medical…

Read More

UBS expects to seal Credit Suisse takeover as early as June 12

By John Revill ZURICH (Reuters) -UBS expects to complete its takeover of Credit Suisse “as early as June 12”, which will create a giant Swiss bank with a balance sheet of $1.6 trillion following a government-backed rescue earlier this year. The deal’s completion is subject to the registration statement, which covers shares to be delivered,…

Read More